Synthesis and PASS-assisted evaluation of coumarin–benzimidazole derivatives as potential anti-inflammatory and anthelmintic agents
Tóm tắt
Two series of novel derivatives have been designed by coupling medicinally important coumarin and benzimidazole nuclei through different linkers. These compounds have been predicted to be potent anti-inflammatory and anthelmintic by in silico studies using PASS (prediction of activity spectra for substances) software. The compounds are synthesized and evaluated for the predicted activities as well as for their in vitro antioxidant potential. Compounds of first series (4a–4f) are found good to moderate anti-inflammatory agents. Among these, compounds 4b and 4f exhibited maximum anti-inflammatory activity (45% inhibition), which is equivalent to the activity of indomethacin (48% inhibition) after 3 h (peak inflammatory response time). Compounds of second series (5a–5f) exhibit anthelmintic activity. Amongst these, compound 5f has mortality activity marginally higher than albendazole (10–11 s). Compound 5e is found to be the most potent antioxidant with remarkable EC50 value (0.08 µM/mL), which is though a little less than that of ascorbic acid (0.03 µM/mL). In addition, a comparative analysis of calculated Lipinski’s parameters reveals that all test compounds have the propensity to be orally bioavailable. Based on these findings, compounds 4b, 4f, 5e, and 5f are identified as new leads to develop potent anti-inflammatory, anthelmintic, and antioxidant compounds.
Tài liệu tham khảo
Ajaiyeoba EO, Onocha PA, Olarenwaju OT (2001) In vitro anthelmintic properties of Buchholzia coriaceae and Gynandropsis gynandra extract. Pharm Biol 39:217–220
Anand P, Singh B, Singh N (2012) A review on coumarins as acetylcholinesterase inhibitors for Alzheimer’s disease. Bioorg Med Chem 20:1175–1180
Bansal Y, Sethi P, Bansal G (2013) Coumarin: a potential nucleus for anti-inflammatory molecules. Med Chem Res 22:3049–3060
Bansal Y, Silakari O (2012) The therapeutic journey of benzimidazoles: a review. Bioorg Med Chem 20:6208–6236
Chu D, Kovacs B (1977) Anti-inflammatory activity in oak gall extracts. Arch Int Pharmacodyn Ther 230:166–176
Curini M, Epifano F, Maltese F, Marcotullio MC, Gonzales SP, Rodriguez JC (2003) Synthesis of Collinin, an antiviral coumarin. Aust J Chem 56:59–60
Fereidoni M, Ahmadiani A, Semnanian S, Javan M (2000) An accurate and simple method for measurement of paw edema. J Pharmacol Toxicol Methods 43:11–14
Gormley NA, Orphanides G, Meyer A, Cullis PM, Maxwell A (1996) The interaction of coumarin antibiotics with fragments of the DNA Gyrase B protein. Biochemistry 35:5083–5092
Leonard NL, Daviy CY, Karl BM (1947) Sulfonate salts of substituted benzimidazoles. J Med Chem 69:2459–2461
Li YF, Wang GF, He PL, Huang WG, Zhu FH, Gao HY, Tang W, Luo Y, Feng CL, Shi LP (2006) Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives. J Med Chem 49:4790–4794
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3–25
Locatelli M, Gindro R, Travaglia F, Coïsson JD, Rinaldi M, Arlorio M (2009) Study of the DPPH-scavenging activity: development of a free software for the correct interpretation of data. Food Chem 114:889–897
Madhavan GR, Balraju V, Mallesham B, Chakrabarti R, Lohray VB (2003) Novel coumarin derivatives of heterocyclic compounds as lipid-lowering agents. Bioorg Med Chem Lett 13:2547–2551
Manvar A, Bavishi A, Radadiya A, Patel J, Vora V, Dodia N, Rawal K, Shah A (2011) Diversity oriented design of various hydrazides and their in-vitro evaluation against Mycobacterium tuberculosis H37RV strains. Bioorg Med Chem Lett 21:4728–4731
Manwar A, Malde A, Verma J, Virsodia V, Mishra A, Upadhyay K, Acharya H, Coutinho E, Shah A (2008) Synthesis, anti-tubercular activity and 3D-QSAR study of coumarin-4-acetic acid benzylidene hydrazides. Eur J Med Chem 43:2395–2403
Montalbetti Christian AGN, Falque V (2005) Amide bond formation and peptide coupling. Tetrahedron 61:10827–10852
Paul K, Bindal S, Luxami V (2013) Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity. Bioorg Med Chem Lett 23:3667–3672
Poroikov VV, Filimonov DA, Borodina VY, Lagunin AA, Kos A (2000) Robustness of biological activity spectra predicting by computer program PASS for non-congeneric sets of chemical compounds. J Chem Inf Comput Sci 40:1349–1355
Riveiro ME, Moglioni A, Vazquez R, Gomez N, Facorro G, Piehl L, de Celis ER, Shayo C, Davio C (2008) Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells. Bioorg Med Chem 16:2665–2675
Sandhu S, Bansal Y, Silakari O, Bansal G (2014) Coumarin hybrids as novel therapeutic agents. Bioorg Med Chem 22:3806–3814
Tsay S, Hwu JR, Singh R, Huang W, Chang YH, Hsu M, Shieh F, Lin C, Hwang KC, Horng J, Clercq ED, Vliegen I, Neyts J (2013) Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit hepatitis C virus. Eur J Med Chem 63:290–298
Tsukamoto G, Yoshino K, Kohono T, Ohtaka H, Kagaya H, Ito K (1980) Synthesis and anti-inflammatory activity of some 2-(substituted-pyridinyl) benzimidazole derivatives. J Med Chem 23:734–738
Winter CE, Risley EA, Nuss GW (1963) Anti-inflammatory and antipyretic activities of indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic acid. J Pharmacol 3:369–376
Wu L, Wang X, Xu W, Farzaneh F, Xu R (2009) The structure and pharmacological functions of coumarin and their derivatives. Curr Med Chem 16:4236–4260